Epithelial Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Epithelial Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-12-08Clinical Trial Update: Ovarian Cancer Vaccine for Patients Who Have Progressed During the CAN-003 Study [Phase 2]
Phase 2 trial update on Prima BioMed's ovarian cancer vaccine for patients who progressed during CAN-003, with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-11-21Clinical Trial Update: Veliparib and Radiation Therapy in Treating Patients With Advanced Solid Malignancies With Peritoneal Carcinomatosis, Epithelial Ovarian, Fallopian, or Primary Peritoneal Cancer [Phase 1]
Phase 1 trial evaluating veliparib in combination with radiation therapy in adults with advanced solid tumors featuring peritoneal carcinoma…
-
CLINICAL_TRIALS trial_result · 2017-10-19Clinical Trial Update: Plasma ctDNA Detection in Diagnosis of Epithelial Ovarian Cancer.
A completed clinical trial evaluating plasma ctDNA detection as a diagnostic tool for epithelial ovarian cancer. The study status is COMPLET…
-
FDA approval · 2017-09-14FDA Approved: MVASI — Original Application (Amgen, Inc)
The FDA approved MVASI (bevacizumab-awwb) from Amgen as a biosimilar to Avastin, marking the original application granting U.S. approval for…
-
CLINICAL_TRIALS trial_result · 2017-07-21Clinical Trial Update: Combination Study Of SB-485232 (Interleukin 18) And Doxil For Advanced Stage Epithelial Ovarian Cancer [Phase 1]
A completed Phase 1 trial evaluating the safety of combining SB-485232 (interleukin-18) with Doxil (liposomal doxorubicin) in advanced epith…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2017-07-19Clinical Trial Update: Perioperative Assessment of Right Ventricular Function and Venous Return in Patients With Epithelial Ovarian Cancer Undergoing Cytoreductive Surgery (Gyn Right) - Pilot Study
A pilot clinical trial evaluating perioperative assessment of right ventricular function and venous return in epithelial ovarian cancer pati…
-
CLINICAL_TRIALS trial_result · 2017-06-28Clinical Trial Update: Safety and Efficacy Clinical Study of SNS-595 in Patients With Platinum-Resistant Ovarian Cancer [Phase 2]
A Phase 2 trial evaluating SNS-595 in platinum-resistant epithelial ovarian cancer has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2017-05-31Clinical Trial Update: Study on Neutropenia Induced by Adjuvant Paclitaxel/Carboplatin Chemotherapy in Patients With Epithelial Ovarian Cancer
Clinical trial update notes neutropenia observed in patients with epithelial ovarian cancer receiving adjuvant paclitaxel/carboplatin chemot…
-
CLINICAL_TRIALS withdrawal · 2017-04-21Clinical Trial Update: N-acetylcysteine Given IV With Cisplatin and Paclitaxel in Patients With Ovarian Cancer [Phase 1]
A Phase 1 trial of intravenous N-acetylcysteine with cisplatin and paclitaxel for ovarian cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-02-10Clinical Trial Update: Live After an Epithelial Ovarian Cancer: Multidisciplinary Assessment of Effects and Long-term Remission in Patients Needs. [NA]
Completed clinical trial update on epithelial ovarian cancer describing multidisciplinary assessment and observations related to long-term r…
-
CLINICAL_TRIALS trial_result · 2016-12-14Clinical Trial Update: Cvac as Maintenance Treatment in Patients With Epithelial Ovarian Cancer in Complete Remission Following First-line Chemotherapy or Second-line Treatment [Phase 2]
Phase 2 trial evaluating CVac as maintenance therapy in epithelial ovarian cancer patients in complete remission after first-line or second-…
-
CLINICAL_TRIALS trial_result · 2016-12-08Clinical Trial Update: Cisplatin Induction With Paclitaxel Consolidation for Stage III-IV Epithelial Ovarian and Primary Peritoneal Cancer [Phase 2]
Phase II trial assessing cisplatin induction with paclitaxel consolidation for stage III-IV epithelial ovarian cancer and primary peritoneal…
-
CLINICAL_TRIALS trial_result · 2016-09-22Clinical Trial Update: Belotecan Versus Topotecan for Recurrent Ovarian Cancer: A Randomized, Open-label, Parallel-group Phase IIb Trial [Phase 2]
A randomized Phase IIb trial comparing belotecan with topotecan for recurrent epithelial ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-08-04Clinical Trial Update: Ovarian Cancer Vaccine for Patients in Remission [Phase 2]
Phase 2 trial update for an ovarian cancer vaccine in patients in remission; the study is completed and results were posted in 2016.
-
CLINICAL_TRIALS research · 2016-07-26Clinical Trial Update: Total/Subtotal Colectomy in Ovarian Cancer [Phase 2]
Phase 2 clinical trial evaluating total/subtotal colectomy in ovarian cancer and related gynecologic cancers; conditions include epithelial …
-
CLINICAL_TRIALS trial_result · 2016-05-12Clinical Trial Update: A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers [Phase 2]
Phase 2 study evaluating MM-121 (seribantumab) in combination with paclitaxel for platinum-resistant/refractory advanced ovarian, fallopian …
-
CLINICAL_TRIALS trial_result · 2016-05-03Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy [Phase 1]
Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of quisinostat in combination with chemotherapy in patients with non…
-
CLINICAL_TRIALS trial_result · 2016-03-25Clinical Trial Update: Taxol/ Carboplatin as First Line Therapy in Patients With Epithelial Ovarian Cancer [Phase 2]
A Phase 2 trial evaluating first-line paclitaxel (Taxol) plus carboplatin for epithelial ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-01-28Clinical Trial Update: Surgical Trial Comparing LIGASURE Assisted Recto-Sigmoid Resection and Omentectomy Compared to Stand [NA]
A completed surgical trial comparing LIGASURE-assisted recto-sigmoid resection with omentectomy to the standard approach in epithelial ovari…
-
CLINICAL_TRIALS trial_result · 2016-01-14Clinical Trial Update: Study of Birinapant in Combination With Conatumumab in Subjects With Relapsed Ovarian Cancer [Phase 1]
A Phase 1 clinical trial evaluating the combination of birinapant and conatumumab in relapsed ovarian and related cancers has completed.
-
CLINICAL_TRIALS trial_result · 2016-01-12Clinical Trial Update: Study of Adding AMG 479 to First Line Chemotherapy in Patients With Optimally Debulked Epithelial Ovarian Cancer [Phase 2]
A Phase 2 trial adding AMG 479 to first-line chemotherapy for optimally debulked epithelial ovarian cancer was terminated, with results post…
-
CLINICAL_TRIALS trial_result · 2015-12-23Clinical Trial Update: A Study to Compare CAELYX With Topotecan HCL in Patients With Recurrent Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy [Phase 3]
Phase 3 trial comparing CAELYX (pegylated liposomal doxorubicin) to topotecan hydrochloride in recurrent epithelial ovarian cancer after fai…
-
CLINICAL_TRIALS trial_result · 2015-12-23Clinical Trial Update: Carboplatin With or Without Gemcitabine in Treating Patients With Advanced Ovarian Epithelial Cancer That Has Not Responded to Previous Chemotherapy [Phase 3]
A Phase 3 trial comparing carboplatin alone versus carboplatin with gemcitabine in patients with advanced epithelial ovarian cancer that has…
-
CLINICAL_TRIALS trial_result · 2015-12-17Clinical Trial Update: Multi-national, Randomized, Phase III, GCIG Intergroup Study Comparing Pegylated Liposomal Doxorubicin (CAELYX) and Carboplatin vs. Paclitaxel and Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse. (CALYPSO) [NA]
Multinational Phase III randomized trial CALYPSO comparing pegylated liposomal doxorubicin (CAELYX) with carboplatin vs paclitaxel with carb…
-
CLINICAL_TRIALS trial_result · 2015-09-29Clinical Trial Update: AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR [Phase 1]
A Phase 1 trial evaluated AMG-386 in combination with either pegylated liposomal doxorubicin or topotecan in advanced recurrent epithelial o…